EcoDrugPlus

Proteasome Subunit Beta 11

Ensembl ID : ENSCGOG00000002053
Gene Symbol: PSMB11
1 Cross references
170 Possible Orthologues:

Proteasome Subunit Beta Type-5-Like

Ensembl ID : ENSCGOG00000002044
Gene Symbol: LOC115022783
3 Cross references
223 Possible Orthologues:

Proteasome Subunit Beta Type-6-Like

Ensembl ID : ENSCGOG00000017078
Gene Symbol: LOC115006306
3 Cross references
227 Possible Orthologues:

Proteasome Subunit Beta Type-6-Like

Ensembl ID : ENSCGOG00000021854
Gene Symbol: LOC115004601
3 Cross references
227 Possible Orthologues:

Proteasome Subunit Beta Type-7-Like

Ensembl ID : ENSCGOG00000014791
Gene Symbol: LOC115016418
3 Cross references
172 Possible Orthologues:

Proteasome Subunit Beta Type-7-Like

Ensembl ID : ENSCGOG00000010818
Gene Symbol: LOC115017064
3 Cross references
215 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSCGOG00000002081
Gene Symbol: PRMT5
3 Cross references
199 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSCGOG00000017430
Gene Symbol: LOC115028758
3 Cross references
203 Possible Orthologues:

Protein Kinase C Alpha Type-Like

Ensembl ID : ENSCGOG00000024390
Gene Symbol: LOC115010783
3 Cross references
212 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSCGOG00000017771
Gene Symbol: PRKCB
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSCGOG00000003116
Gene Symbol: LOC115017865
3 Cross references
205 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSCGOG00000021757
Gene Symbol: PRKCD
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).